Why the study?
What are the kinetics of NT-proBNP compared to other cardiac biomarkers in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
Observational (n=600)
What are the kinetics of NT-proBNP compared to other cardiac biomarkers in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
NT-proBNP exhibits slow normalization kinetics up to 3 months post-PCI in ACS patients, unlike other cardiac biomarkers, suggesting prolonged neurohormonal activation especially in high-risk individuals.
The aim of this research was to describe N-terminal part of the prohormone B-type natriuretic peptide (NT-proBNP) levels over time in patients with acute coronary syndrome (ACS) before and after percutaneous coronary intervention (PCI). NT-proBNP, troponin I (Tn-I), creatine kinase (CK), CK MB isoenzyme (CKMB), fibrinogen, D-dimers, and C-reactive protein (CRP) were measured in 300 consecutive patients with ACS before undergoing successful reperfusion with PCI in the first 48 hours, 2 days after, and at the end of the 1st, 3rd, 6th, 12th, 18th, and 24th month. The concentration of NT-proBNP was cross-correlated with the levels of NT-proBNP in 300 patients without ACS and was significantly increased before and after PCI and at the end of the 3rd month, contrasting with the fast conversion to normal levels of Tn-I, CK, CKMB, fibrinogen, D-dimers, and CRP. In patients with ACS undergoing successful PCI, NT-proBNP shows slow kinetics, especially in patients with an increased thrombolysis in myocardial infarction risk score, hypertension, and diabetes. Nevertheless, cardiac neurohormonal activation may be a unifying feature among patients at high risk for cardiovascular events after ACS and PCI.
No takes yet. Share an insight, caveat, or question.
Λαμπρόπουλος et al. (2010) conducted an observational in Acute coronary syndrome (n=600). Acute coronary syndrome and percutaneous coronary intervention vs. Patients without acute coronary syndrome was evaluated on N-terminal prohormone B-type natriuretic peptide (NT-proBNP) levels over time.
Synapse has enriched 10 related papers. Consider them for comparative context: